Literature DB >> 20103563

Xenobiotic, bile acid, and cholesterol transporters: function and regulation.

Curtis D Klaassen1, Lauren M Aleksunes.   

Abstract

Transporters influence the disposition of chemicals within the body by participating in absorption, distribution, and elimination. Transporters of the solute carrier family (SLC) comprise a variety of proteins, including organic cation transporters (OCT) 1 to 3, organic cation/carnitine transporters (OCTN) 1 to 3, organic anion transporters (OAT) 1 to 7, various organic anion transporting polypeptide isoforms, sodium taurocholate cotransporting polypeptide, apical sodium-dependent bile acid transporter, peptide transporters (PEPT) 1 and 2, concentrative nucleoside transporters (CNT) 1 to 3, equilibrative nucleoside transporter (ENT) 1 to 3, and multidrug and toxin extrusion transporters (MATE) 1 and 2, which mediate the uptake (except MATEs) of organic anions and cations as well as peptides and nucleosides. Efflux transporters of the ATP-binding cassette superfamily, such as ATP-binding cassette transporter A1 (ABCA1), multidrug resistance proteins (MDR) 1 and 2, bile salt export pump, multidrug resistance-associated proteins (MRP) 1 to 9, breast cancer resistance protein, and ATP-binding cassette subfamily G members 5 and 8, are responsible for the unidirectional export of endogenous and exogenous substances. Other efflux transporters [ATPase copper-transporting beta polypeptide (ATP7B) and ATPase class I type 8B member 1 (ATP8B1) as well as organic solute transporters (OST) alpha and beta] also play major roles in the transport of some endogenous chemicals across biological membranes. This review article provides a comprehensive overview of these transporters (both rodent and human) with regard to tissue distribution, subcellular localization, and substrate preferences. Because uptake and efflux transporters are expressed in multiple cell types, the roles of transporters in a variety of tissues, including the liver, kidneys, intestine, brain, heart, placenta, mammary glands, immune cells, and testes are discussed. Attention is also placed upon a variety of regulatory factors that influence transporter expression and function, including transcriptional activation and post-translational modifications as well as subcellular trafficking. Sex differences, ontogeny, and pharmacological and toxicological regulation of transporters are also addressed. Transporters are important transmembrane proteins that mediate the cellular entry and exit of a wide range of substrates throughout the body and thereby play important roles in human physiology, pharmacology, pathology, and toxicology.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20103563      PMCID: PMC2835398          DOI: 10.1124/pr.109.002014

Source DB:  PubMed          Journal:  Pharmacol Rev        ISSN: 0031-6997            Impact factor:   25.468


  1255 in total

1.  Structure and expression of the human MDR (P-glycoprotein) gene family.

Authors:  J E Chin; R Soffir; K E Noonan; K Choi; I B Roninson
Journal:  Mol Cell Biol       Date:  1989-09       Impact factor: 4.272

2.  Characterization of the drug resistance and transport properties of multidrug resistance protein 6 (MRP6, ABCC6).

Authors:  Martin G Belinsky; Zhe-Sheng Chen; Irina Shchaveleva; Hao Zeng; Gary D Kruh
Journal:  Cancer Res       Date:  2002-11-01       Impact factor: 12.701

3.  Carnitine membrane transporter deficiency: a long-term follow up and OCTN2 mutation in the first documented case of primary carnitine deficiency.

Authors:  Stephen D Cederbaum; Samantha Koo-McCoy; Ingrid Tein; Betty Y L Hsu; Arupa Ganguly; Eric Vilain; Katrina Dipple; Ljerka Cvitanovic-Sojat; Charles Stanley
Journal:  Mol Genet Metab       Date:  2002-11       Impact factor: 4.797

4.  Gene expression levels and immunolocalization of organic ion transporters in the human kidney.

Authors:  Hideyuki Motohashi; Yuji Sakurai; Hideyuki Saito; Satohiro Masuda; Yumiko Urakami; Maki Goto; Atsushi Fukatsu; Osamu Ogawa; Ken-Ichi Inui
Journal:  J Am Soc Nephrol       Date:  2002-04       Impact factor: 10.121

5.  MRP8, a new member of ABC transporter superfamily, identified by EST database mining and gene prediction program, is highly expressed in breast cancer.

Authors:  T K Bera; S Lee; G Salvatore; B Lee; I Pastan
Journal:  Mol Med       Date:  2001-08       Impact factor: 6.354

6.  A novel putative transporter maps to the osteosclerosis (oc) mutation and is not expressed in the oc mutant mouse.

Authors:  K P Brady; H Dushkin; D Förnzler; T Koike; F Magner; H Her; S Gullans; G V Segre; R M Green; D R Beier
Journal:  Genomics       Date:  1999-03-15       Impact factor: 5.736

7.  Experimental LPS-induced cholestasis alters subcellular distribution and affects colocalization of Mrp2 and Bsep proteins: a quantitative colocalization study.

Authors:  Vadim Zinchuk; Olga Zinchuk; Teruhiko Okada
Journal:  Microsc Res Tech       Date:  2005-06-01       Impact factor: 2.769

8.  Expression, localisation and activity of ATP binding cassette (ABC) family of drug transporters in human amnion membranes.

Authors:  I L M H Aye; J W Paxton; D A Evseenko; J A Keelan
Journal:  Placenta       Date:  2007-05-07       Impact factor: 3.481

9.  Association of SLC22A4/5 polymorphisms with steroid responsiveness of inflammatory bowel disease in Japan.

Authors:  Seiya Nakahara; Yoshiaki Arimura; Katsuhiko Saito; Akira Goto; Satoshi Motoya; Yasuhisa Shinomura; Atsushi Miyamoto; Kohzoh Imai
Journal:  Dis Colon Rectum       Date:  2008-02-15       Impact factor: 4.585

10.  The organic cation transporter-3 is a pivotal modulator of neurodegeneration in the nigrostriatal dopaminergic pathway.

Authors:  Mei Cui; Radha Aras; Whitney V Christian; Phillip M Rappold; Mamata Hatwar; Joseph Panza; Vernice Jackson-Lewis; Jonathan A Javitch; Nazzareno Ballatori; Serge Przedborski; Kim Tieu
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-29       Impact factor: 11.205

View more
  254 in total

1.  Effects of aging on mRNA profiles for drug-metabolizing enzymes and transporters in livers of male and female mice.

Authors:  Zidong Donna Fu; Iván L Csanaky; Curtis D Klaassen
Journal:  Drug Metab Dispos       Date:  2012-03-23       Impact factor: 3.922

2.  α-Tocopherol injections in rats up-regulate hepatic ABC transporters, but not cytochrome P450 enzymes.

Authors:  Maret G Traber; Edwin M Labut; Scott W Leonard; Katie M Lebold
Journal:  Free Radic Biol Med       Date:  2011-09-03       Impact factor: 7.376

Review 3.  Organic and inorganic transporters of the testis: A review.

Authors:  David M Klein; Nathan J Cherrington
Journal:  Spermatogenesis       Date:  2015-01-07

Review 4.  The blood-epididymis barrier and inflammation.

Authors:  Mary Gregory; Daniel G Cyr
Journal:  Spermatogenesis       Date:  2014-12-31

Review 5.  MicroRNA Pharmacoepigenetics: Posttranscriptional Regulation Mechanisms behind Variable Drug Disposition and Strategy to Develop More Effective Therapy.

Authors:  Ai-Ming Yu; Ye Tian; Mei-Juan Tu; Pui Yan Ho; Joseph L Jilek
Journal:  Drug Metab Dispos       Date:  2015-11-13       Impact factor: 3.922

6.  S-allylmercaptocysteine improves nonalcoholic steatohepatitis by enhancing AHR/NRF2-mediated drug metabolising enzymes and reducing NF-κB/IκBα and NLRP3/6-mediated inflammation.

Authors:  Qian Yu; Yann-Yin Lee; Zheng-Yun Xia; Emily C Liong; Jia Xiao; George L Tipoe
Journal:  Eur J Nutr       Date:  2020-06-17       Impact factor: 5.614

7.  In utero exposure to di-(2-ethylhexyl) phthalate induces testicular effects in neonatal rats that are antagonized by genistein cotreatment.

Authors:  Steven Jones; Annie Boisvert; Sade Francois; Liandong Zhang; Martine Culty
Journal:  Biol Reprod       Date:  2015-08-26       Impact factor: 4.285

8.  Novel Interactions between Gut Microbiome and Host Drug-Processing Genes Modify the Hepatic Metabolism of the Environmental Chemicals Polybrominated Diphenyl Ethers.

Authors:  Cindy Yanfei Li; Soowan Lee; Sara Cade; Li-Jung Kuo; Irvin R Schultz; Deepak K Bhatt; Bhagwat Prasad; Theo K Bammler; Julia Yue Cui
Journal:  Drug Metab Dispos       Date:  2017-09-01       Impact factor: 3.922

9.  Xenobiotic transporter expression along the male genital tract.

Authors:  David M Klein; Stephen H Wright; Nathan J Cherrington
Journal:  Reprod Toxicol       Date:  2014-05-09       Impact factor: 3.143

10.  Renal xenobiotic transporter expression is altered in multiple experimental models of nonalcoholic steatohepatitis.

Authors:  Mark J Canet; Rhiannon N Hardwick; April D Lake; Anika L Dzierlenga; John D Clarke; Michael J Goedken; Nathan J Cherrington
Journal:  Drug Metab Dispos       Date:  2014-12-08       Impact factor: 3.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.